IL-21R BLOCKADE REDUCES ATHEROSCLEROSIS DEVELOPMENT IN LDLR-/- MICE

被引：0
|
作者：
Postel, R. J. [1 ]
Smit, V. [2 ]
De Mol, J. [1 ]
Kleijn, M. N. A. Bernabe [2 ]
De Jong, M. J. M. [1 ]
Delfos, L. [2 ]
Hemme, E. [2 ]
Depuydt, M. A. C. [2 ]
Bot, I. [2 ]
Kuiper, J. [2 ]
Foks, A. C. [2 ]
机构：
[1] LACDR, Biotherapeut, Leiden, Netherlands
[2] Leiden Univ, LACDR, Biotherapeut, Leiden, Netherlands
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP067
引用
收藏
页码：E105 / E106
页数：2
相关论文
共 50 条
  • [1] IL-21R blockade reduces atherosclerosis development in young female LDLr-/- mice
    Postel, Rimke
    de Mol, Jill
    Smit, Virginia
    Lievaart, Eva
    Kleijn, Mireia Bernabe
    Verwilligen, Robin
    de Jong, Maaike
    Delfos, Lucie
    Hemme, Esmeralda
    Bot, Ilze
    Kuiper, Johan
    Foks, Amanda
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 389 - 389
  • [2] IL-21R BLOCKADE REDUCES ATHEROSCLEROSIS DEVELOPMENT
    Snijckers, R.
    De Mol, J.
    Smit, V.
    Postel, R.
    Lievaart, E.
    Kleijn, M. Bernabe
    Depuydt, M. A. C.
    Bot, I.
    Kuiper, J.
    Foks, A.
    ATHEROSCLEROSIS, 2023, 379 : S26 - S26
  • [3] Hematopoietic knockdown of PPARδ reduces atherosclerosis in LDLR-/- mice
    Li, G.
    Chen, C.
    Laing, S. D.
    Ballard, C.
    Biju, K. C.
    Reddick, R. L.
    Clark, R. A.
    Li, S.
    GENE THERAPY, 2016, 23 (01) : 78 - 85
  • [4] Mildronate, a Regulator of Energy Metabolism, Reduces Atherosclerosis in apoE/LDLR-/- Mice
    Vilskersts, Reinis
    Liepinsh, Edgars
    Mateuszuk, Lukasz
    Grinberga, Solveiga
    Kalvinsh, Ivars
    Chlopicki, Stefan
    Dambrova, Maija
    PHARMACOLOGY, 2009, 83 (05) : 287 - 293
  • [5] MHCII-Deficiency attenuates the development of atherosclerosis in LDLR-/- Mice
    Smock, Marjan L.
    Heeringa, Peter
    van de Gaar, Jose
    Daemen, Mat J.
    Willem, Jan
    Tervaert, Cohen
    Lingens, Esther
    CIRCULATION, 2006, 114 (18) : 287 - 287
  • [6] Adipsin deficiency does not impact atherosclerosis development in Ldlr-/- mice
    Liu, Longhua
    Chan, Michelle
    Yu, Lexiang
    Wang, Weidong
    Qiang, Li
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2021, 320 (01): : 87 - 92
  • [7] Dietary phosphatidylcholine supplementation reduces atherosclerosis in Ldlr-/- male mice2
    Aldana-Hernandez, Paulina
    Azarcoya-Barrera, Jessy
    Veen, Jelske N. van der
    Leonard, Kelly-Ann
    Zhao, Yuan-Yuan
    Nelson, Randal
    Goruk, Susan
    Field, Catherine J.
    Curtis, Jonathan M.
    Richard, Caroline
    Jacobs, Rene L.
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2021, 92
  • [8] The PPARδ agonist GW0742X reduces atherosclerosis in LDLR-/- mice
    Graham, TL
    Mookherjee, C
    Suckling, KE
    Palmer, CNA
    Patel, L
    ATHEROSCLEROSIS, 2005, 181 (01) : 29 - 37
  • [9] Therapeutic silencing of FSP27 reduces the progression of atherosclerosis in Ldlr-/- mice
    Rajamoorthi, Ananthi
    Lee, Richard G.
    Baldan, Angel
    ATHEROSCLEROSIS, 2018, 275 : 43 - 49
  • [10] Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-/- Mice
    Bisgaard, Line S.
    Bosteen, Markus H.
    Fink, Lisbeth N.
    Sorensen, Charlotte M.
    Rosendahl, Alexander
    Mogensen, Christina K.
    Rasmussen, Salka E.
    Rolin, Bidda
    Nielsen, Lars B.
    Pedersen, Tanja X.
    PLOS ONE, 2016, 11 (12):
12345